康妇消炎栓联合金刚藤片治疗慢性盆腔炎后盆腔痛的疗效观察

Clinical observation on Kangfu Xiaoyan Suppository combined with Jin'gangteng Tablet in the treatment of pelvic pain after chronic pelvic inflammatory disease

目的:探讨康妇消炎栓联合金刚藤片治疗慢性盆腔炎(PID)后盆腔痛的效果。方法:将我院妇产科门诊就诊的慢性盆腔痛患者150例随机分为A、B、C组。A组50例给予康妇消炎栓治疗,1粒/晚,纳肛,30 d为1个疗程,连用2个疗程;B组50例给予金刚藤片治疗,4片/次,3次/d,30 d为1个疗程,连用2个疗程;C组50例给予康妇消炎栓联合金刚藤片治疗,用药方法为A组+B组,连用2个疗程。对三组连续随访2个月。结果:治疗30 d后,症状体征评分及评分改善比例,A组为35.50分、(62.53±15.87)%,B组为34.66分、(58.62±16.75)%,C组为29.54分、(67.70±17.55)%,C组与A、B组比较差异有高度统计学意义(P<0.01)。治疗60 d后,症状体征评分及评分改善比例,A组为26.51分、(82.46±13.63)%,B组为24.56分、(80.41±15.82)%,C组为23.89分、(84.75±15.67)%,C组与A、B组比较差异无统计学意义(P>0.05)。结论:口服金刚藤片与直肠用康妇消炎栓联合应用,对治疗PID后盆腔痛有良好疗效。

Objective：To investigate the effect on Kangfu Xiaoyan Suppository combined with Jin＇gangteng Tablet in the treatment of pelvic pain after chronic pelvic inflammatory disease.Methods：150 patients with pelvic pain from out-patient department of obstetrics and gynecology,who were divided into group A,group B and group C.Group A was given Kangfu Xiaoyan Suppository,1 pill at bedtime into anus,3 times a day with 30 days of course of the treatment for 2 months;group B was given Jin＇gangteng Tablet,4 pills one time,3 times a day with 30 days of course of the treatment for 2 months;group C was given the treatment of groupA plus group B.The follow-up of 3 groups were visited for 2 months.Results：After 30 days treatment,the symptoms and signs score and its improvement rate,group A were 35.50 scores,（62.53±15.87）%;group B were 34.66 scores,（58.62±16.75）%;group C were 29.54 scores,（67.70±17.55）%;group C had significant differences compared with group B and C（P〈0.01）.After 60 days treatment,the symptoms and signs score and its improvment rate,group A were 26.51 scores,（82.46±13.63）%;group B were 24.56 scores,（80.41±15.82）%;group C were 23.89 scores,（84.75±15.67）%;but there was no significant difference between group A,B and C（P〉0.05）.Conclusion：Kangfu Xiaoyan Suppository combined with Jin＇gangteng Tablet in the treatment of pelvic pain after chronic pelvic inflammatory disease has a good curative effect.